Inventor

DAVIS MICHAEL GLEN

US2 patents

Patents

2 patents

US7226755B1Jun 5, 2007

HPTPbeta as a target in treatment of angiogenesis mediated disorders

PROCTER & GAMBLE68 citations94

US7632862B2Dec 15, 2009

Pharmaceutical compositions that modulate HPTPbeta activity

PROCTER & GAMBLE35 citations89